Oura Officially Files for IPO as Revenue Soars to $1.2 Billion
Oura, the Finnish company behind the popular smart rings, has officially taken the plunge into the public markets. On Thursday, it submitted its IPO paperwork to the U.S. Securities and Exchange Commission (SEC), giving investors a rare peek into its financial health. And the numbers are impressive: revenue jumped from $697 million to $1.2 billion in the nine months ending June 30. That's a hefty leap, especially when you consider the company had earlier projected around $500 million for all of 2024, $1 billion for 2025, and nearly $2 billion for 2026. It seems Oura is outpacing its own expectations.
So, what's driving this growth? For starters, Oura has sold roughly 3.6 million smart rings in the past year alone. These sleek devices, priced between $350 and $400, track everything from heart rate and metabolism to stress and sleep. But the real magic happens in the companion app, which turns raw data into personalized health insights. With about 5 million paid members and a 12-month weighted average retention rate of 85%, it's clear that people aren't just buying a gadget—they're buying into a lifestyle.
Founded in 2013 in Finland, Oura has come a long way from its early days. It confidentially filed for an IPO back in May, and market chatter suggested the company was aiming to raise around $3 billion, with a potential valuation of $16 billion. That would be a significant bump from the $11 billion valuation it commanded in October 2025. Clearly, investors are bullish on the future of wearable health tech.
But Oura isn't resting on its laurels. The company has its sights set on expanding beyond fitness tracking into broader healthcare territory. It's forging deeper partnerships with insurance companies, employers, and healthcare providers, aiming to position its rings as essential tools for preventive care. With over 50 health indicators and nearly 4.2 billion hours of physiological data collected, Oura plans to leverage this treasure trove to train AI and machine learning models. The goal? To enhance health pattern recognition, deliver more personalized recommendations, and even predict potential health issues before they arise.
However, not everything is smooth sailing. Oura is currently facing a proposed class-action lawsuit that accuses the company of misleading consumers about the accuracy of its sleep tracking features. Oura has denied the allegations and says it will vigorously defend itself in court. This legal hurdle adds a layer of uncertainty to the IPO, but it also highlights the growing scrutiny on health claims made by wearable tech companies.
This IPO is more than just a financial milestone for Oura—it's a litmus test for the entire smart wearable industry. As companies shift from selling hardware to offering subscription-based services and AI-driven health insights, Oura's performance on the public market will be closely watched. Will investors buy into the vision of a future where our rings know us better than we know ourselves? Only time will tell.
Key Points
- Oura has officially filed for an IPO with the SEC.
- Revenue surged to $1.2 billion in the nine months ending June 30, up from $697 million.
- The company has sold 3.6 million rings and has 5 million paid members.
- Oura plans to expand into healthcare and use AI for predictive health insights.
- A class-action lawsuit over sleep tracking accuracy is pending.